**Core Concept**
The question requires knowledge of the best contraceptive option for a patient with a specific medical condition, in this case, rheumatic heart disease. The underlying principle is the selection of a contraceptive method that does not increase the risk of thromboembolic events or worsen the patient's cardiac condition.

**Why the Correct Answer is Right**
The correct answer is **Combined Oral Contraceptives (COCs) with a progestin-only pill (POP)** is not the best choice for this patient. For patients with a history of rheumatic heart disease, the American Heart Association recommends avoiding estrogen-containing contraceptives, such as COCs, due to the increased risk of thromboembolic events. However, a progestin-only pill is a safer alternative for these patients.

**Why Each Wrong Option is Incorrect**
**Option A:** **Intrauterine Device (IUD)**. This option is not the best choice because while IUDs are generally safe, there is a small risk of pelvic inflammatory disease (PID), which may be a concern for patients with rheumatic heart disease. However, this risk is relatively low and not the primary reason for choosing a different option.
**Option B:** **Barrier Methods**. While barrier methods, such as condoms, are safe for patients with rheumatic heart disease, they may not be as effective as hormonal contraceptives for some women.
**Option C:** **Injections**. Depot medroxyprogesterone acetate (DMPA) injections are a form of progestin-only contraception but are not the best choice for patients with rheumatic heart disease due to potential effects on blood pressure and the risk of cardiovascular events.

**Clinical Pearl / High-Yield Fact**
When selecting a contraceptive method for a patient with a medical condition, consider the potential effects of the contraceptive on the underlying condition and the patient's overall health.

**Correct Answer:** D. Progestin-only pill